Safety of the extension of use of galacto‐oligosaccharides (GOS) as a novel food in food for special medical purposes pursuant to Regulation (EU) 2015/2283.

MLA

Turck, Dominique, et al. “Safety of the Extension of Use of Galacto‐oligosaccharides (GOS) as a Novel Food in Food for Special Medical Purposes Pursuant to Regulation (EU) 2015/2283.” EFSA Journal, vol. 20, no. 3, Mar. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.2903/j.efsa.2022.7203.

APA

Turck, D., Bohn, T., Castenmiller, J., De Henauw, S., Hirsch, E. K. I., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., Pelaez, C., Pentieva, K., Siani, A., Thies, F., Tsabouri, S., Vinceti, M., Cubadda, F., Frenzel, T., Heinonen, M., Marchelli, R., & Neuhäuser, B. M. (2022). Safety of the extension of use of galacto‐oligosaccharides (GOS) as a novel food in food for special medical purposes pursuant to Regulation (EU) 2015/2283. EFSA Journal, 20(3), 1–7. https://doi.org/10.2903/j.efsa.2022.7203

Chicago

Turck, Dominique, Torsten Bohn, Jacqueline Castenmiller, Stefaan De Henauw, Ernst, Karen Ildico Hirsch, Alexandre Maciuk, Inge Mangelsdorf, et al. 2022. “Safety of the Extension of Use of Galacto‐oligosaccharides (GOS) as a Novel Food in Food for Special Medical Purposes Pursuant to Regulation (EU) 2015/2283.” EFSA Journal 20 (3): 1–7. doi:10.2903/j.efsa.2022.7203.